Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka
- PMID: 31126253
- PMCID: PMC6534844
- DOI: 10.1186/s12881-019-0815-x
Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka
Abstract
Background: Cystic fibrosis has been largely under-diagnosed and thus, limited data is available on the incidence of cystic fibrosis in Sri Lanka. Our aim is to describe the phenotypic and genotypic spectrum of children with cystic fibrosis in Sri Lanka.
Case presentation: This report describes 10 unrelated cystic fibrosis cases with phenotypic features of cystic fibrosis and abnormal or intermediate sweat tests. The most common phenotypic features in this sample of symptomatic patients were persistent or recurrent lower respiratory tract infections, failure to thrive and Pseudo-Bartter syndrome. Altogether 7 cystic fibrosis causing mutations were identified in 10 patients. Except delta F508 which is the commonest mutation worldwide all the other mutations detected in Sri Lankan patients are rare mutations. 1161delC and V456A detected in our patients are South Asian mutations. The other mutations such as [C.1282C > G; C.2738A > G], C.53 + 1G > C, 2184insA and a deletion encompassing exons 4 to 11 have been reported previously from European patients with cystic fibrosis.
Conclusion: These cases highlight the importance of considering the diagnosis of cystic fibrosis in children and young adults presenting with persistent respiratory tract infections associated with severe malnutrition and Pseudo-Bartter syndrome, especially in low income countries where newborn screening for cystic fibrosis is not available. The spectrum of CFTR mutations in Sri Lanka is heterogeneous and possibly linked to genetic flow from Indian subcontinent and Europe. The common mutations should be identified by sequencing the entire CFTR gene in adequate number of cystic fibrosis patients in order to design a mutation panel for common regional mutations.
Keywords: Cystic fibrosis; Gene sequencing; Mutations; Phenotypic features; Sri Lanka.
Conflict of interest statement
The authors declare that they have no competing interest.
Similar articles
-
Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.PLoS One. 2015 Jul 24;10(7):e0133890. doi: 10.1371/journal.pone.0133890. eCollection 2015. PLoS One. 2015. PMID: 26208274 Free PMC article.
-
[Correlation between phenotype and genotype in a group of patients with cystic fibrosis].Rev Med Chil. 2002 May;130(5):475-81. Rev Med Chil. 2002. PMID: 12143267 Spanish.
-
Diverse genotypical features and impacts on clinical course and severity of cystic fibrosis: early childhood experience.Minerva Pediatr. 2011 Jun;63(3):169-75. Minerva Pediatr. 2011. PMID: 21654597
-
Exploring the diversity of CFTR gene mutations in cystic fibrosis individuals of South Asia.J Asthma. 2024 Jun;61(6):511-519. doi: 10.1080/02770903.2023.2297365. Epub 2023 Dec 28. J Asthma. 2024. PMID: 38153325 Review.
-
[Molecular basis of phenotype heterogeneity in cystic fibrosis].Ann Biol Clin (Paris). 1997 Mar-Apr;55(2):113-21. Ann Biol Clin (Paris). 1997. PMID: 9180964 Review. French.
Cited by
-
Functional variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are associated with increased risk of colorectal cancer.Hum Mol Genet. 2025 Mar 20;34(7):617-625. doi: 10.1093/hmg/ddaf007. Hum Mol Genet. 2025. PMID: 39825500
-
Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis.Mediators Inflamm. 2020 Mar 25;2020:5696185. doi: 10.1155/2020/5696185. eCollection 2020. Mediators Inflamm. 2020. PMID: 32308556 Free PMC article.
-
Genetic attributes of Iranian cystic fibrosis patients: the diagnostic efficiency of CFTR mutations in over a decade.Front Genet. 2023 May 18;14:1140034. doi: 10.3389/fgene.2023.1140034. eCollection 2023. Front Genet. 2023. PMID: 37274793 Free PMC article.
-
Genetic Heterogeneity Correlated with Phenotypic Variability in 48 Patients with Cystic Fibrosis.J Clin Med. 2025 Jul 29;14(15):5362. doi: 10.3390/jcm14155362. J Clin Med. 2025. PMID: 40806984 Free PMC article.
-
Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center.Lung India. 2022 May-Jun;39(3):274-278. doi: 10.4103/lungindia.lungindia_370_21. Lung India. 2022. PMID: 35488686 Free PMC article.
References
-
- Welsh MJ, Ramsay BW, Accurso F, Cutting GR. Cystic Fibrosis. In: WS SABCS, Valle D, editors. Molecular and Metabolic Basis of Inherited Disease. 8th ed: McGrow-Hill; Newyork, 2001. p. 5121–88.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical